Relevance of Fluorinated Ligands to the Design of Metallodrugs for Their Potential Use in Cancer Treatment

Fluorination of pharmaceutical agents has afforded crucial modifications to their pharmacological profiles, leading to important advances in medicinal chemistry. On the other hand, metallodrugs are considered to be valuable candidates in the treatment of several diseases, albeit with the caveat that...

Full description

Bibliographic Details
Main Authors: José C. Páez-Franco, Miriam R. Zermeño-Ortega, Carmen Myriam de la O-Contreras, Daniel Canseco-González, Jesus R. Parra-Unda, Alcives Avila-Sorrosa, Raúl G. Enríquez, Juan M. Germán-Acacio, David Morales-Morales
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/14/2/402
_version_ 1797477211580661760
author José C. Páez-Franco
Miriam R. Zermeño-Ortega
Carmen Myriam de la O-Contreras
Daniel Canseco-González
Jesus R. Parra-Unda
Alcives Avila-Sorrosa
Raúl G. Enríquez
Juan M. Germán-Acacio
David Morales-Morales
author_facet José C. Páez-Franco
Miriam R. Zermeño-Ortega
Carmen Myriam de la O-Contreras
Daniel Canseco-González
Jesus R. Parra-Unda
Alcives Avila-Sorrosa
Raúl G. Enríquez
Juan M. Germán-Acacio
David Morales-Morales
author_sort José C. Páez-Franco
collection DOAJ
description Fluorination of pharmaceutical agents has afforded crucial modifications to their pharmacological profiles, leading to important advances in medicinal chemistry. On the other hand, metallodrugs are considered to be valuable candidates in the treatment of several diseases, albeit with the caveat that they may exhibit pharmacological disadvantages, such as poor water solubility, low bioavailability and short circulating time. To surmount these limitations, two approaches have been developed: one based on the design of novel metallodrug-delivering carriers and the other based on optimizing the structure of the ligands bound to the metal center. In this context, fluorination of the ligands may bring beneficial changes (physicochemical and biological) that can help to elude the aforementioned drawbacks. Thus, in this review, we discuss the use of fluorinated ligands in the design of metallodrugs that may exhibit potential anticancer activity.
first_indexed 2024-03-09T21:14:26Z
format Article
id doaj.art-de0466249f3545c4a9d8dd7e62625230
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-09T21:14:26Z
publishDate 2022-02-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-de0466249f3545c4a9d8dd7e626252302023-11-23T21:38:44ZengMDPI AGPharmaceutics1999-49232022-02-0114240210.3390/pharmaceutics14020402Relevance of Fluorinated Ligands to the Design of Metallodrugs for Their Potential Use in Cancer TreatmentJosé C. Páez-Franco0Miriam R. Zermeño-Ortega1Carmen Myriam de la O-Contreras2Daniel Canseco-González3Jesus R. Parra-Unda4Alcives Avila-Sorrosa5Raúl G. Enríquez6Juan M. Germán-Acacio7David Morales-Morales8Red de Apoyo a la Investigación, Coordinación de la Investigación Científica-UNAM, Instituto Nacional de Ciencias Médicas y Nutrición SZ, Ciudad de Mexico CP 14000, MexicoFacultad de Ciencias Químicas, Universidad Autónoma de Chihuahua (UACH), Circuito Universitario S/N, Chihuahua CP 31125, Chihuahua, MexicoFacultad de Ciencias Químicas, Universidad Autónoma de Chihuahua (UACH), Circuito Universitario S/N, Chihuahua CP 31125, Chihuahua, MexicoCONACYT-Laboratorio Nacional de Investigación y Servicio Agroalimentario y Forestal, Universidad Autónoma Chapingo, Texcoco de Mora CP 56230, MexicoSchool of Chemical and Biological Sciences, Autonomous University of Sinaloa (Ciudad Universitaria), Culiacan CP 80010, Sinaloa, MexicoDepartamento de Química Orgánica, Instituto Politécnico Nacional, Escuela Nacional de Ciencias Biológicas, Carpio y Plan de Ayala S/N, Colonia Santo Tomás, Ciudad de Mexico CP 11340, MexicoInstituto de Química, Universidad Nacional Autónoma de México, Circuito Exterior, Ciudad Universitaria, Ciudad de Mexico CP 04510, MexicoRed de Apoyo a la Investigación, Coordinación de la Investigación Científica-UNAM, Instituto Nacional de Ciencias Médicas y Nutrición SZ, Ciudad de Mexico CP 14000, MexicoInstituto de Química, Universidad Nacional Autónoma de México, Circuito Exterior, Ciudad Universitaria, Ciudad de Mexico CP 04510, MexicoFluorination of pharmaceutical agents has afforded crucial modifications to their pharmacological profiles, leading to important advances in medicinal chemistry. On the other hand, metallodrugs are considered to be valuable candidates in the treatment of several diseases, albeit with the caveat that they may exhibit pharmacological disadvantages, such as poor water solubility, low bioavailability and short circulating time. To surmount these limitations, two approaches have been developed: one based on the design of novel metallodrug-delivering carriers and the other based on optimizing the structure of the ligands bound to the metal center. In this context, fluorination of the ligands may bring beneficial changes (physicochemical and biological) that can help to elude the aforementioned drawbacks. Thus, in this review, we discuss the use of fluorinated ligands in the design of metallodrugs that may exhibit potential anticancer activity.https://www.mdpi.com/1999-4923/14/2/402organometallicscoordination complexesmetallodrugsfluorinated ligandsanticancer activitycancer
spellingShingle José C. Páez-Franco
Miriam R. Zermeño-Ortega
Carmen Myriam de la O-Contreras
Daniel Canseco-González
Jesus R. Parra-Unda
Alcives Avila-Sorrosa
Raúl G. Enríquez
Juan M. Germán-Acacio
David Morales-Morales
Relevance of Fluorinated Ligands to the Design of Metallodrugs for Their Potential Use in Cancer Treatment
Pharmaceutics
organometallics
coordination complexes
metallodrugs
fluorinated ligands
anticancer activity
cancer
title Relevance of Fluorinated Ligands to the Design of Metallodrugs for Their Potential Use in Cancer Treatment
title_full Relevance of Fluorinated Ligands to the Design of Metallodrugs for Their Potential Use in Cancer Treatment
title_fullStr Relevance of Fluorinated Ligands to the Design of Metallodrugs for Their Potential Use in Cancer Treatment
title_full_unstemmed Relevance of Fluorinated Ligands to the Design of Metallodrugs for Their Potential Use in Cancer Treatment
title_short Relevance of Fluorinated Ligands to the Design of Metallodrugs for Their Potential Use in Cancer Treatment
title_sort relevance of fluorinated ligands to the design of metallodrugs for their potential use in cancer treatment
topic organometallics
coordination complexes
metallodrugs
fluorinated ligands
anticancer activity
cancer
url https://www.mdpi.com/1999-4923/14/2/402
work_keys_str_mv AT josecpaezfranco relevanceoffluorinatedligandstothedesignofmetallodrugsfortheirpotentialuseincancertreatment
AT miriamrzermenoortega relevanceoffluorinatedligandstothedesignofmetallodrugsfortheirpotentialuseincancertreatment
AT carmenmyriamdelaocontreras relevanceoffluorinatedligandstothedesignofmetallodrugsfortheirpotentialuseincancertreatment
AT danielcansecogonzalez relevanceoffluorinatedligandstothedesignofmetallodrugsfortheirpotentialuseincancertreatment
AT jesusrparraunda relevanceoffluorinatedligandstothedesignofmetallodrugsfortheirpotentialuseincancertreatment
AT alcivesavilasorrosa relevanceoffluorinatedligandstothedesignofmetallodrugsfortheirpotentialuseincancertreatment
AT raulgenriquez relevanceoffluorinatedligandstothedesignofmetallodrugsfortheirpotentialuseincancertreatment
AT juanmgermanacacio relevanceoffluorinatedligandstothedesignofmetallodrugsfortheirpotentialuseincancertreatment
AT davidmoralesmorales relevanceoffluorinatedligandstothedesignofmetallodrugsfortheirpotentialuseincancertreatment